Hamburg on Schein board

Margaret Hamburg, the nominee for FDA commissioner, sits on the board of Henry Schein, a pharmaceuticals and medical device distribution company. As reported by Politics and Critical Thinking, Hamburg received about $200,000 of Schein stock on March 9, just before she was nominated by Obama. What does this mean? Is this a parting gift? Would an industry trying to buy government policy do something so transparent and try with only $200k when Hamburg is married to the director of Renaissance Technologies? The crazy view is presented by Health Care Renewal:

Given that Dr Hamburg has spent over five years living with the obligation for unyielding loyalty to the interests of Henry Schein...

...um, okay... A more restrained and thoughtful viewpoint is expressed by Adam Fein, who is excited about the possibility of having someone at FDA who understands business distribution models.